BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Mammotome Introduces In Room MRI Guided Breast Biopsy System To Improve Clinical Workflow

Mammotome, a Danaher company, announces the Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System, the industry's first system designed t...

February 19, 2026 | News

Innovent Advances IBI354 Into Pivotal Phase Three Trial For HER2 Positive Advanced Breast Cancer

Innovent Biologics, Inc. ("Innovent",HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medi...

February 16, 2026 | News

Alphamab Oncology Advances JSKN003 Into Phase III Trial For HER2 Positive Advanced Colorectal Cancer

Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-005...

February 16, 2026 | News

Kelun Biotech Wins China Approval For Sacituzumab Tirumotecan In Advanced Breast Cancer

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that a new indication application for its TROP2-dir...

February 09, 2026 | News

Imagion Biosystems Files FDA IND For MagSense Molecular MRI Cancer Imaging Platform

Imagion Biosystems, Ltd. (ASX: IBX) announced that the company has lodged an Investigational New Drug (IND) application with the U.S. Food and Drug Adminis...

February 06, 2026 | News

Kazia Therapeutics Reports Encouraging Early Responses For Paxalisib Combination In Advanced Triple Negative Breast Cancer

Kazia Therapeutics provided a clinical update from its ongoing Phase 1b study evaluating paxalisib in combination with pembrolizumab and chemothe...

January 29, 2026 | News

Bio Sourcing And Zerion Pharma Secure Eurostars Funding To Develop Oral Trastuzumab For HER2 Breast Cancer

Bio‑Sourcing and Zerion Pharma A/S announce that their joint project to develop an oral formulation of Trastuzumab, the pioneer monoclonal antibody...

January 16, 2026 | News

KORU Medical Submits FDA 510k For FreedomEDGE Use With PHESGO In HER2 Positive Breast Cancer

KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on t...

January 01, 2026 | News

Intas Pharmaceuticals Limited Secures Exclusive Needle Free Injection Technology For IVF And Gynecology In India

Intas Pharmaceuticals Limited (“Intas”), a leading multinational pharmaceutical company, has entered into an exclusive agreement with ...

December 30, 2025 | News

Alphamab Oncology Secures IND Acceptance In China For JSKN033 Phase II Cervical Cancer Study

Alphamab Oncology (Stock Code: 9966.HK) announced that the IND application for a Phase II clinical study of JSKN033 (a proprietary high-concentration subcu...

December 30, 2025 | News

Japan Approves Guardant360 CDx As First Blood Based Companion Diagnostic For ESR1 Mutations In Breast Cancer

Guardant360® CDx is the first companion diagnostic to be approved in Japan to identify ESR1 mutations in patients with hormone receptor-posit...

December 23, 2025 | News

Alphamab Oncology’s JSKN003 Gains FDA Breakthrough Therapy Designation For Platinum Resistant Ovarian Cancer

Alphamab Oncology (stock code: 9966.HK) announced that the biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003, independently developed by the...

December 23, 2025 | News

PT Fapon Bioindustries Indonesia And Bio Farma Sign Strategic IVD Manufacturing Partnership

PT Fapon Bioindustries Indonesia (referred to as "PT Fapon") and the Indonesian state-owned pharmaceutical holding company PT Bio Farma (Persero) (referred...

December 09, 2025 | News

Lunit Submits FDA 510k For AI Driven Five Year Breast Cancer Risk Prediction Model

Submission marks a key regulatory milestone toward bringing SEER-calibrated, imaging-based risk assessment to U.S. screening programs Lunit (KRX:328130), ...

December 09, 2025 | News

Stay Connected